Welcome to our dedicated page for RAD news (Ticker: RAD), a resource for investors and traders seeking the latest updates and insights on RAD stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect RAD's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of RAD's position in the market.
Bartell Drugs has partnered with Uber Technologies (NYSE: UBER) to enhance on-demand delivery services in the Puget Sound region. Customers can now order healthcare and grocery products from all 67 Bartell's locations via Uber Eats. This initiative ensures quick delivery and includes perks for Uber Pass and Eats Pass subscribers, such as $0 delivery on certain orders. This partnership aligns with Uber's strategy to provide convenience in shopping, reinforcing its goal to facilitate access to essential products for consumers. Bartell Drugs is owned by Rite Aid Corporation, which also expands its delivery network with Uber.
Rite Aid (NYSE: RAD) has expanded its partnership with Uber Technologies, Inc. (NYSE: UBER) to provide nationwide delivery of Rite Aid products via Uber Eats. This initiative allows customers to order essential healthcare and grocery items from 2,185 Rite Aid locations across 17 states. The service features no delivery fees for Uber Pass and Eats Pass holders, in addition to discounts on orders over $15. This collaboration aims to enhance customer convenience and reflects changing consumer shopping habits.
Rite Aid reported a 2.2% increase in revenues from continuing operations, reaching $6.11 billion for the second quarter. However, the company faced a substantial net loss of $100.3 million or $1.86 per share, compared to the previous year’s loss of $13.2 million. Adjusted net loss stood at $22 million with adjusted EBITDA at $106.2 million, down from $151.6 million a year prior. The company has improved its financial flexibility by amending its credit agreement, extending its debt maturity to 2026. Looking ahead, Rite Aid raised its fiscal 2022 adjusted EBITDA guidance.
Rite Aid (NYSE: RAD) has partnered with CLEAR (NYSE: YOU) to provide customers with a secure digital vaccine card for COVID-19 vaccinations. Customers can easily access this card via CLEAR’s app after receiving their vaccinations at Rite Aid locations. This initiative aims to facilitate proof of vaccination for various activities, particularly as requirements increase across states and businesses. Rite Aid has administered over seven million vaccinations, showcasing its commitment to community health.
Rite Aid (NYSE: RAD) announced a new corporate headquarters in location value="LU/us.pa.phldph"Philadelphia, reflecting a remote-first work strategy. The headquarters will enhance collaboration among its over 2,800 corporate associates, who prefer remote work while desiring in-person interaction. Planned regional collaboration centers aim to facilitate meetings and training across the country. CEO Heyward Donigan emphasized this transformation highlights Rite Aid's commitment to modernizing its workforce and improving flexibility, recruitment, and work-life balance for employees.
Elixir, a subsidiary of Rite Aid (NYSE: RAD), has appointed Lance Neill as its new Chief Operating Officer. Neill brings extensive experience from his previous roles, including Vice President of Network Development at Centene, managing a $32 billion pharmacy spend. He will oversee core operations and strategic development at Elixir. CEO Heyward Donigan emphasized Elixir's importance in Rite Aid's growth strategy, highlighting Neill's qualifications to enhance operational excellence and strategic priorities.
Rite Aid Corporation (NYSE:RAD) will announce its Fiscal 2022 Second Quarter financial results on September 23, 2021, following the quarter ending August 28, 2021. An analyst call will take place at 8:30 a.m. Eastern Time, featuring comments from the management team. The call will be available via webcast, with a replay accessible at Rite Aid's Investor Relations page. Additionally, a telephone replay will be available from 12:00 p.m. ET on September 23 until 11:59 p.m. ET on October 24.
Rite Aid (NYSE: RAD) and BioReference, an OPKO Health company (NASDAQ: OPK), will provide free COVID-19 testing for New York State public school students ahead of the 2021-2022 school year. This ‘Back to School’ program allows students aged 4-17 to access RT-PCR tests at 115 Rite Aid drive-thru locations. Testing is voluntary, with results delivered digitally to parents. Governor Kathy Hochul emphasized the program's importance in combating the Delta variant and ensuring safe school environments. The initiative aligns with federal efforts to expand school testing.
Rite Aid Corporation (NYSE: RAD) announced an amendment to its senior secured credit agreement, introducing a $2.8 billion asset-based revolving credit facility and a $350 million first-in, last-out senior secured term loan. These amended facilities extend debt maturity to August 2026, providing improved pricing for the term loan. The interest rates on the new facilities are lower than previous rates, signaling confidence from the financial community and supporting Rite Aid's strategic objectives under its RxEvolution strategy.
Rite Aid (NYSE: RAD) has announced the availability of flu vaccines at all its stores, alongside an expanded COVID-19 online scheduling tool for flu and ancillary vaccinations. This initiative aims to simplify the vaccination process as CDC warns of increased flu infection rates. Rite Aid offers various flu vaccination options, including quadrivalent and high-dose vaccines for those aged 65 and older. The online scheduling system allows customers to book appointments easily while ensuring a seamless healthcare experience, part of Rite Aid's RxEvolution strategy.